🔎 Trials Near Me

Dachaigh › Glioma › Texas › Houston

Sgrùdaidhean clionaigeach Glioma ann an Houston, TX

Tha 23 sgrùdaidhean airson Glioma a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

A’ fastadhÌre 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
12 Months – 21 Years · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

A’ fastadhÌre 1/2
  • Baylor College of Medicine, Houston
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04094610

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

A’ fastadhÌre 1
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT03896568

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

A’ fastadhÌre 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06838676

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

A’ fastadh
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04373720

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

A’ fastadhSgrùdadh amharc
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04771806

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

A’ fastadhÌre 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
36 Months · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

A’ fastadhÌre 2
  • Texas Children's Hospital, Houston
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

A’ fastadhÌre 3
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

A’ fastadhÌre 2
  • Texas Children's Hospital, Houston
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05096481

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

A’ fastadhSgrùdadh amharc
  • M D Anderson Cancer Center, Houston
Gach aois · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT01772771

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

A’ fastadhÌre 1/2
  • Research Site, Houston
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT05417594

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

A’ fastadhÌre 1
  • Excel Diagnostics & Nuclear Oncology Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

A’ fastadhÌre 1
  • Texas Children's Hospital, Houston
12 Months – 25 Years · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT04099797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A’ fastadhÌre 2
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
  • Texas Children's Hospital, Houston
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

A’ fastadhÌre 1 tràth
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT05804227

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

A’ fastadhÌre 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

A’ fastadhÌre 1 tràth
  • Texas Children's Hospital, Houston
Suas gu aois 21 · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT04655404

Sgrùdaidhean Glioma ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.